Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Puma Biotechnology, Inc. (PBYI) had Return on Tangible Equity of 34.98% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$228.37M |
|
$31.11M |
|
$58.16M |
|
$170.21M |
|
$191.07M |
|
$37.30M |
|
$-1.52M |
|
$35.78M |
|
$35.78M |
|
$31.11M |
|
$31.11M |
|
$31.11M |
|
$31.11M |
|
$37.30M |
|
$48.24M |
|
50.01M |
|
50.65M |
|
$0.62 |
|
$0.61 |
|
| Balance Sheet Financials | |
$162.69M |
|
$0.19M |
|
$53.62M |
|
$216.30M |
|
$81.25M |
|
-- |
|
$4.71M |
|
$85.96M |
|
$130.34M |
|
$88.95M |
|
$130.34M |
|
50.41M |
|
| Cash Flow Statement Financials | |
$41.80M |
|
$-36.19M |
|
$-45.20M |
|
$71.31M |
|
$31.73M |
|
$-39.58M |
|
$6.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.00 |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
74.53% |
|
16.33% |
|
16.33% |
|
21.12% |
|
15.67% |
|
13.62% |
|
$41.73M |
|
-- |
|
-- |
|
-- |
|
1.06 |
|
10.55 |
|
4.26 |
|
85.75 |
|
23.87% |
|
|
Return on Tangible Equity |
34.98% |
14.38% |
|
23.87% |
|
$2.59 |
|
$0.82 |
|
$0.83 |
|